title: Management of hereditary angioedema: 2010 Canadian approach.
abstract: C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadian Consensus Conference on the diagnosis, therapy and management of HAE. We have formed the Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH) - http://www.haecanada.com to advance care of patients with this disorder in Canada. We here present a review of management of HAE in Canada.
authors.affiliation: Canadian Hereditary Angioedema Network (CHAEN)/Réseau Canadien d'Angioédème Héréditaire (RCAH), 705 South Tower, 3031 Hospital Dr, NW Calgary, Alberta, Canada. tbowen@pol.net.
authors.forename: Tom
authors.initials: T
authors.lastname: Bowen
authors.forename: John
authors.initials: J
authors.lastname: Brosz
authors.forename: Kristylea
authors.initials: K
authors.lastname: Brosz
authors.forename: Jacques
authors.initials: J
authors.lastname: Hebert
authors.forename: Bruce
authors.initials: B
authors.lastname: Ritchie